Renal side effects of VEGF-blocking therapy
Author(s) -
Janina MüllerDeile,
Verena Bröcker,
Viktor Grünwald,
Markus Hiss,
Anna Bertram,
S. Kubicka,
A. Ganser,
Hermann Haller,
Mario Schiffer
Publication year - 2009
Publication title -
clinical kidney journal
Language(s) - English
Resource type - Journals
eISSN - 2048-8513
pISSN - 2048-8505
DOI - 10.1093/ndtplus/sfp175
Subject(s) - medicine , sunitinib , bevacizumab , vascular endothelial growth factor , tyrosine kinase inhibitor , proteinuria , renal cell carcinoma , tyrosine kinase , cancer research , oncology , cancer , gastroenterology , urology , kidney , chemotherapy , receptor , vegf receptors
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom